These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8902396)

  • 21. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
    Khan A; Tomita Y; Sykes M
    Transplantation; 1996 Aug; 62(3):380-7. PubMed ID: 8779687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation tolerance and mixed chimerism: at the frontier of clinical application.
    Donckier V; Toungouz M; Goldman M
    Transpl Int; 2001; 14(1):1-5. PubMed ID: 11263549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA; Ildstad ST
    Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion?
    van Pel M; van Breugel DW; van Wijk M; Luypen S; Vingerhoed J; Roholl PJ; Boog CJ
    Transpl Immunol; 2003; 11(3-4):375-84. PubMed ID: 12967790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts.
    Prigozhina T; Slavin S
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):169-85. PubMed ID: 15368079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.
    Peggs KS; Mackinnon S; Williams CD; D'Sa S; Thuraisundaram D; Kyriakou C; Morris EC; Hale G; Waldmann H; Linch DC; Goldstone AH; Yong K
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):257-65. PubMed ID: 12720218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
    Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
    Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In utero transplantation of rat hematopoietic stem cells induces xenogeneic chimerism in mice.
    Rice HE; Hedrick MH; Flake AW
    Transplant Proc; 1994 Feb; 26(1):126-8. PubMed ID: 7906444
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymic transplantation across an MHC class I barrier in swine.
    Haller GW; Esnaola N; Yamada K; Wu A; Shimizu A; Hansen A; Ferrara VR; Allison KS; Colvin RB; Sykes M; Sachs DH
    J Immunol; 1999 Oct; 163(7):3785-92. PubMed ID: 10490976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
    Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
    Clin Exp Immunol; 2001 Jan; 123(1):162-9. PubMed ID: 11168014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34+ donor marrow cells.
    Allen MD; Weyhrich J; Gaur L; Akimoto H; Hall J; Dalesandro J; Sai S; Thomas R; Nelson KA; Andrews RG
    Cell Immunol; 1997 Nov; 181(2):127-38. PubMed ID: 9398400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of immune unresponsiveness by intrathymic injection of allogeneic cells in a murine model.
    Sherburne CG; Onyekaba CO; Condie RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):307-11. PubMed ID: 8438313
    [No Abstract]   [Full Text] [Related]  

  • 36. Intrathymic tolerance induction: determination of tolerance to class II major histocompatibility complex antigens in maturing T lymphocytes by a bone marrow-derived non-lymphoid thymus cell.
    Zepp F; Cussler K; Mannhardt W; Schofer O; Schulte-Wissermann H
    Scand J Immunol; 1987 Dec; 26(6):589-601. PubMed ID: 3501157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT.
    Mickelson DM; Sproat L; Dean R; Sobecks R; Rybicki L; Kalaycio M; Pohlman B; Sweetenham J; Andresen S; Bolwell B; Copelan EA
    Bone Marrow Transplant; 2011 Jan; 46(1):84-9. PubMed ID: 20305699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance.
    Neipp M; Exner BG; Ildstad ST
    Transplantation; 1998 Oct; 66(8):969-75. PubMed ID: 9808477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine stem cell engraftment and seeding of murine thymus with class II+ cells in mice expressing porcine cytokines: toward tolerance induction across discordant xenogeneic barriers.
    Chen AM; Zhou Y; Swenson K; Sachs DH; Sykes M; Yang YG
    Transplantation; 2000 Jun; 69(12):2484-90. PubMed ID: 10910267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.